NR3C1 and glioblastoma: It would be appropriate to mention a study in the human section that knocked out glucocorticoid receptor gene in anti-IL13Rα2 CAR T cells against glioblastoma, to enable the use of high-dose dexamethasone without fearing of its detrimental effects on CAR Ts; although the overall treatment design did not produce promising results [214].